Showing results (1401-1410 of 1,489) with videos related to
Sort By:
Pageof 149
Cancers|October 16, 2025
Safety of Post-Transplant Cyclophosphamide-Based Prophylaxis in AML Patients with Pre-Existing Cardiac Morbidity Undergoing Allogeneic Hematopoietic Cell TransplantationArnau Torrent-Rodríguez, Enric Cascos, Víctor Navarro Garcés, et al.Nature|January 24, 2020
Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancerEmily J Faivre, Keith F McDaniel, Daniel H Albert, et al.Acta Psychiatrica Scandinavica|September 3, 2025
Influence of Sex and Diagnosis on Clinical Variables and Neurocognitive Performance in Severe Mental Illness. Results From the PsyCourse StudyMaria Serra-Navarro, Maria Heilbronner, Brisa Solé, et al.Acta Psychiatrica Scandinavica|September 1, 2025
Unravelling the Link Between Body Mass Index and Cognitive Performance in Individuals With Bipolar Disorder and Exploration of PRS Moderation Effect: Findings From the PsyCourse StudyB Solé, L Montejo, M Budde, et al.American Journal of Epidemiology|October 24, 2018
Integrating Clinical and Epidemiologic Data on Allergic Diseases Across Birth Cohorts: A Harmonization Study in the Mechanisms of the Development of Allergy ProjectMarta Benet, Richard Albang, Mariona Pinart, et al.Circulation Research|February 10, 2026
Cardiac Macrophages and Fibroblasts Modulate Atrial Fibrillation MaintenanceAna Simon-Chica, Jorge G Quintanilla, Carlos Torroja, et al.The Lancet. Respiratory Medicine|February 8, 2014
Comorbidity of eczema, rhinitis, and asthma in IgE-sensitised and non-IgE-sensitised children in MeDALL: a population-based cohort studyMariona Pinart, Marta Benet, Isabella Annesi-Maesano, et al.Nature|September 28, 2017
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumoursLoren M Lasko, Clarissa G Jakob, Rohinton P Edalji, et al.Nature Chemical Biology|January 31, 2017
The EED protein-protein interaction inhibitor A-395 inactivates the PRC2 complexYupeng He, Sujatha Selvaraju, Michael L Curtin, et al.Haematologica|November 3, 2022
Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trialsCelia González-Gil, Mireia Morgades, Thaysa Lopes, et al.Pageof 149